在阿拉巴马州,糖尿病患者的医疗补助计划受益人中,与血红蛋白A1C检测相关的患者级因素
Caroline A Presley1, Yulia Khodneva1, Carrie R Howell1
1Department of Medicine, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, United States.
Primary care diabetes
|October 20, 2023
概括
在阿拉巴马州有2型糖尿病的成年医疗补助受益者中,有超过三分之一的人每年至少接受两次血红蛋白A1c (HbA1c) 测试. 根据医疗补助资格类别,测试率有很大差异.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 糖尿病管理 糖尿病管理
- 健康 公平 卫生 公平
背景情况:
- 2型糖尿病的管理需要定期监测血红蛋白A1c (HbA1c).
- 了解弱势群体之间的测试差异对于改善护理至关重要.
研究的目的:
- 为了确定与HbA1c测试频率相关的患者级因素.
- 根据阿拉巴马州的医疗补助资格 (残疾与贫困) 测试率的差异.
主要方法:
- 对19-64岁的2型糖尿病成年人医疗补助申请数据 (2011-2020年) 的回顾性分析.
- 多变量波桑回归用于评估与每年≥1和≥2个HbA1c测试相关的因素.
- 根据医疗补助资格理由分层分析.
主要成果:
- 总的来说,57%的观察有≥1个HbA1c测试,35%每年有≥2个测试.
- 基于残疾的医疗补助受益者比基于贫困的受益者有更高的测试率 (76% ≥1,49% ≥2) (38% ≥1,20% ≥2).
- 诸如种族,年龄,性别,农村地区,胰岛素使用,专家护理,并发症和访问等因素与测试概率有关,根据资格群体而异.
结论:
- 只有不到一半的2型糖尿病的阿拉巴马州成人医疗补助受益人每年满足了推的≥2个HbA1c测试.
- 测试频率存在显著差异,这与医疗补助资格和患者一级特征有关.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
557
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
557
Factors Affecting Protein-Drug Binding: Patient-Related Factors
64
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
64
Diabetes: Management and Pharmacotherapy
290
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
290
Pre-Procedural Guidelines for Assessing Blood Pressure
574
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
574
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K


